Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Sponsor
National Cancer Institute, Egypt
Study ID
NCT07110051
Status
Recruiting
Apply to this trial

Conditions

  • Abdominal Surgeries
  • Nalbuphine
  • Pediatric Cancer
  • Tramadol

Eligibility Criteria

Sex
ALL
Age
3 Years - 12 Years
Healthy Volunteers
Not accepted

Interventions

  • Nalbuphine — DRUG
    this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
  • Tramadol — DRUG
    this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).

Study Details

In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.

Key Dates

First listed
Aug 7, 2025
Start date
Jan 15, 2025
Status verified
Aug 2025
Primary completion
Sep 15, 2025
Completion
Oct 15, 2025

Study Design

Enrollment
128 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: nalbuphine (group A)
    group A (nalbuphine) will receive a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
  • Active Comparator: Tramadol (group B)
    group B( Tramadol) will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).

Primary Outcome Measure

time to first rescue analgesia [ Time Frame: 72 hours ]

Central Contacts

Related Studies